Invention Grant
US09359427B2 Methods for culturing human myeloid leukaemia cells and cells derived therefrom
有权
用于培养人类骨髓性白血病细胞和由其衍生的细胞的方法
- Patent Title: Methods for culturing human myeloid leukaemia cells and cells derived therefrom
- Patent Title (中): 用于培养人类骨髓性白血病细胞和由其衍生的细胞的方法
-
Application No.: US13995730Application Date: 2011-12-21
-
Publication No.: US09359427B2Publication Date: 2016-06-07
- Inventor: Rainer Stahn
- Applicant: Rainer Stahn
- Applicant Address: DE Berlin
- Assignee: Glycotope GmbH
- Current Assignee: Glycotope GmbH
- Current Assignee Address: DE Berlin
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent James E. Remillard, Esq.; Jill Gorny Sloper, Esq.
- International Application: PCT/EP2011/073702 WO 20111221
- International Announcement: WO2012/085162 WO 20120628
- Main IPC: C12P21/02
- IPC: C12P21/02 ; C07K16/00 ; C12N5/09
Abstract:
The present invention pertains to a method for culturing a suspension of immortalized human blood cells, preferably cells of myeloid leukaemia origin or cells derived therefrom, wherein said method provides a high productivity, a high cell viability and growth rate and a high batch-to-batch consistency, and can be scaled up without altering these parameters.
Public/Granted literature
- US20130330768A1 METHODS FOR CULTURING HUMAN MYELOID LEUKAEMIA CELLS AND CELLS DERIVED THEREFROM Public/Granted day:2013-12-12
Information query
